Claris Bio private stock trade

Claris Bio

Legal NameClaris Biotherapeutics, Inc.
HeadquartersJersey City, NJ
SectorBioTech

Claris Bio is a biotechnology company specializing in developing novel therapies for the treatment of cancer and other diseases. The company focuses on harnessing the power of immunotherapy and targeted therapies to address unmet medical needs and improve patient outcomes. Claris Bio's expertise lies in leveraging cutting-edge research and innovative technologies to discover and develop promising drug candidates that target specific molecular pathways involved in disease progression. The company aims to empower patients and healthcare providers by providing access to new and effective treatment options that offer hope for better health and quality of life. Ultimately, Claris Bio is committed to advancing the field of biotechnology and making a meaningful impact on the lives of patients worldwide.

Learn more about Claris Bio IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for Claris Bio, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for Claris Bio, log in to ZXData or contact us to request access.
View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.